ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >DNA damage >Topoisomerase inhibitors >Voreloxin

Voreloxin

Voreloxin Structure
CAS No.
175414-77-4
Chemical Name:
Voreloxin
Synonyms
SPC-595;SNS-595;AG-7352;CS-1489;VOSAROXIN;Voreloxin;Voreloxin, >=98%;Voreloxin (SNS-595);Voreloxin USP/EP/BP;SNS-595; VOSAROXIN; AG 7352
CBNumber:
CB92538816
Molecular Formula:
C18H19N5O4S
Molecular Weight:
401.44
MOL File:
175414-77-4.mol
MSDS File:
SDS
Modify Date:
2023/5/21 10:59:17

Voreloxin Properties

Boiling point 652.0±65.0 °C(Predicted)
Density 1.52±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility insoluble in H2O; insoluble in EtOH; insoluble in DMSO
form solid
pka 5.68±0.70(Predicted)

Voreloxin Chemical Properties,Uses,Production

Uses

Voreloxin is a potent Topoisomerase II inhibitor with broad-spectrum anti-tumor activity.

Voreloxin Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 63)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29898 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 25247 58 Inquiry
Baoji Guokang Bio-Technology Co., Ltd. 0917-3909592 13892490616 China 9322 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
ShenZhen Trendseen Biological Technology Co.,Ltd. 13417589054 China 11681 58 Inquiry
Wuhan Topule Biopharmaceutical Co., Ltd +8618327326525 China 8474 58 Inquiry
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo -1-(2-thiazolyl)- Voreloxin (SNS-595) Voreloxin, >=98% Voreloxin AG-7352 SNS-595 SPC-595 AG-7352, 1,4-dihydro-7-[(S,S)-3-Methoxy-4-MethylaMino-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic, (+)-1,4-dihydro-7-[(3S,4S)-3-Methoxy-4-(MethylaMino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid VOSAROXIN 7-((3S,4S)-3-Methoxy-4-(MethylaMino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid 1,4-Dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid 7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid SNS-595; VOSAROXIN; AG 7352 CS-1489 Voreloxin USP/EP/BP 175414-77-4 API Inhibitors